Samudio Ruiz et al. found that the presence of a large amount of epidermal growth factor receptor (EGFR) activators in the ascites of ovarian cancer leaded to sustained overexpression of EGFR and its ligands in the tumor microenvironment. This evidence concerns the gene EGFR and ovarian cancer.